News
Latest News| New Research Shows Potential to Reverse Cancer Wasting
On June 1, 2024, in the journal Nature Communications, scientists from Bo Li's research team published an article titled "Area postrema neurons mediate interleukin-6 function in cancer cachexia". The article found that sustained elevation of interleukin-6 can lead to brain dysfunction and ultimately cancer cachexia.
Latest News | A First-In-Class Selective Inhibitor of EGFR and PI3K Offers A Single-Molecule Approach to Targeting Adaptive Resistance
On July 11, 2024, a team of researchers led by Dr. Judith Sebolt Leopold designed a kinase inhibitor MTX-531 that can block epidermal growth factor receptor (EGFR) and phosphatidylinositol 3-OH kinase (PI3K).
Accelerate Drug Discovery with Biosimilar Antibodies - The Fast Track to Target Binding
Alpha Lifetech's 700+ biosimilar antibodies target EGFR, TNF-α, VEGF, speeding up drug research with validated quality.
Unlocking the Mysteries of Biological Processes: Alpha Lifetech Produces High-Quality Membrane Proteins for Scientists
Alpha Lifetech offers quality membrane proteins for drug discovery and cellular insights, using advanced production techniques.
The Art and Science of Nanobody Discovery: How Alpha Lifetech is Pushing Boundaries
Discover nanobody technology: phage display, immunization, screening, selection, and structural analysis at Alpha Lifetech for diagnostics and therapy.